benidipine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Wu, G; Xu, K; Xu, M | 1 |
| Abe, K; Kanazawa, M; Kohzuki, M; Yasujima, M; Yoshida, K | 1 |
2 other study(ies) available for benidipine and Alloxan Diabetes
| Article | Year |
|---|---|
Benidipine protects kidney through inhibiting ROCK1 activity and reducing the epithelium-mesenchymal transdifferentiation in type 1 diabetic rats.
Topics: Animals; Calcium Channel Blockers; Cell Transdifferentiation; Cytoprotection; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dihydropyridines; Epithelial-Mesenchymal Transition; Fibrosis; Kidney; Male; Rats; Rats, Wistar; rho-Associated Kinases | 2013 |
Effects of benidipine, a calcium antagonist, on urinary kallikrein excretion and renal impairment in experimental diabetes.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Experimental; Dihydropyridines; Kallikreins; Male; Proteinuria; Radioimmunoassay; Rats; Rats, Inbred WKY; Streptozocin | 1996 |